Swiss – Brompton Cardio-Oncology Summit

We are pleased to announce that the third edition of the Swiss-Brompton Cardio-Oncology Summit will take place on March 5–6, 2026, at Riverside, Glattfelden. Transportation will be organized from Zurich Airport as well as from the city of Zurich. Book your tickets to Zurich now!

The first edition in February 2024 was a great success, made possible thanks to our partnerships with many sponsors. The second edition is scheduled for February 13–14, 2025.

The 2026 summit will be an international and educational gathering with a strong focus on cardio-oncology, covering the following main topics:
breast cancer, lung cancer, melanoma, cardiac amyloidosis, and the latest advances in cardio-oncology.

The target audience includes cardiologists, hematologists, oncologists, and internists.

In addition to amyloidosis, other major topics will address cardio-oncology-specific issues such as cardiac dysfunction and heart failure during cancer therapies, optimization of cardiovascular risk factors during and after oncological treatments, hematopoietic stem cell transplantation, CAR-T cell therapy, lymphomas, sarcomas, as well as updates on cancer treatments.

This third edition of the Swiss-Brompton Cardio-Oncology Summit is expected to once again bring together over 150 in-person participants, including cardiologists, oncologists, hematologists, and internists.